GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China

References

• Plummer M, Franceschi S, Munoz N. Epidemiology of gastric cancer. IARC Sci Publ 2004; 157: 311–26
   PubMedGoogle Scholar
• Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006; 12: 17–020
   PubMed Web of Science ®Google Scholar
• Sun X, Mu R, Zhou Y, Dai X, Qiao Y, Zhang S, et al. 1990–1992 mortality of stomach cancer in China. Zhonghua Zhong Liu Za Zhi 2002; 24: 4–8
   PubMedGoogle Scholar
• Stadtlander CT, Waterbor J. Molecular epidemiology pathogenesis and prevention of gastric cancer. Carcinogenesis 1999; 20: 2195–207
   PubMed Web of Science ®Google Scholar
• Correa P. Human gastric carcinogenesis: a multistep and multifactorial process: First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6735–40
   PubMed Web of Science ®Google Scholar
• Stoicov C, Saffari R, Cai X, Hasyagar C, Houghton J. Molecular biology of gastric cancer – Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling. Gene 2004; 341: 1–17
   PubMedGoogle Scholar
• Correa P, Chen VW. Future of gastric cancer prevention. Gastric Cancer 2004; 7: 9–16
   PubMedGoogle Scholar
• Stacey DW. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol 2003; 15: 158–63
   PubMed Web of Science ®Google Scholar
• Arber N, Gammon MD, Hibshoosh H, Britton JA, Zhang Y, Schonberg JB, et al. Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach. Hum Pathol 1999; 30: 1087–92
   PubMed Web of Science ®Google Scholar
• Oda K, Okabayashi T, Kataoka M, Takeda A, Shibuya Y, Orita K, et al. Evaluation of cyclin D1mRNA expression in gastric and colorectal cancers. Res Commun Mol Pathol Pharmacol 1999; 105: 237–52
   PubMedGoogle Scholar
• Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 1995; 11: 1005–11
   PubMed Web of Science ®Google Scholar
• Knudsen KE, Alan Diehl J, Haiman CA, Knudsen ES. CyclinD1 polymorphism, aberrant splicing and cancer risk. Oncogene 2006; 25: 1620–8
   PubMed Web of Science ®Google Scholar
• Zhang J, Li Y, Wang R, Wen D, Sarbia M, Kuang G, et al. Association between CCND1 G870A polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. Int J Cancer 2003; 105: 281–4
   PubMed Web of Science ®Google Scholar
• Song JH, Kim CJ, Cho YG, Park YK, Nam SW, Yoo NJ, et al. Association of cyclin D1 G870A polymorphism with susceptibility to gastric cancers in Korean male patients. Neoplasma 2007; 54: 235–9
   PubMed Web of Science ®Google Scholar
• Geddert H, Kiel S, Zotz RB, Zhang J, Willers R, Gabbert HE, et al. Polymorphism of p16ink4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract. J Cancer Res Clin Oncol 2005; 131: 803–8
   PubMedGoogle Scholar
• Wang L, Chen W, Wang J, Tan Y, Zhou Y, Ding W, et al. Reduced folate carrier gene G80A polymorphism is associated with an increased risk of gastroesophageal cancers in a Chinese population. Eur J Cancer 2006; 42: 3206–11
   PubMed Web of Science ®Google Scholar
• Schneider S, Roessli D, Excoffier L. Arlequin ver. 2.000: A software for population genetics data analysis. In: Genetics and biometry laboratory. Switzerland: University of Geneva; 2000.
   Google Scholar
• Aoyagi K, Koufuji K, Yano S, Murakami N, Terasaki Y, Yamasaki Y, et al. Immunohistochemical study on the expression of cyclin D1 and E in gastric cancer. Kurume Med J 2000; 47: 199–203
   PubMedGoogle Scholar
• Gao P, Zhou GY, Liu Y, Li JS, Zhen JH, Yuan YP. Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance. World J Gastroenterol 2004; 10: 2936–9
   PubMedGoogle Scholar
• Deng L, Zhao X, Pan KF, Wang Y, Deng XY, Lü YY, et al. Cyclin D1 polymorphism and the susceptibility to NPC using DHPLC. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 2002; 34: 16–20
   PubMedGoogle Scholar
• Hong Y, Eu KW, Seow-choen F, Fook-Chong S, Cheah PY. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore. Eur J Cancer 2005; 41: 1037–44
   PubMedGoogle Scholar
• Zhang Y, Chen S, Chen C, Santella RM. Polymorphisms in cyclin D1 gene and hepatocellular carcinoma. Mol Carcinog 2002; 33: 125–9
   PubMed Web of Science ®Google Scholar
• Porter TR, Richards FM, Houlston RS, Evans DG, Jankowski JA, Macdonald F, et al. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 2002; 21: 1928–33
   PubMedGoogle Scholar
• Le Marchand L, Seifried A, Lum-Jones A, Donlon T, Wilkens LR. Association of the cylcin D1 A870G polymorphism with advanced colorectal cancer. JAMA 2003; 290: 2843–8
   PubMedGoogle Scholar
• McKay JA, Douglas JJ, Ross VG, Curran S, Murray GI, Cassidy J, et al. Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Int J Cancer 2000; 88: 77–81
   PubMedGoogle Scholar
• Kong S, Wei Q, Amos CI, Lynch PM, Levin B, Zong J, et al. Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst 2001; 93: 1106–8
   PubMedGoogle Scholar
• Howe D, Lynas C. The cyclin D1 alternative transcripts (a) and (b) are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241. Haematologica 2001; 86: 563–9
   PubMed Web of Science ®Google Scholar
• Hong Y, Eu KW, Seow-Choen F, Fook-Chong S, Cheah PY. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore. Eur J Cancer 2005; 41: 1037–44
   PubMedGoogle Scholar